Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Omega Fund VI, L.P. | 1,184,636 3.600% |
-972,987 (-45.10%) |
Filing History |
| 2024-02-14 4:48 pm Unchanged |
2023-12-31 | 13G | Ikena Oncology, Inc. IKNA |
Omega Fund VI, L.P. | 2,249,123 4.700% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:43 pm Sale |
2023-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Omega Fund VI, L.P. | 0 0.000% |
-2,415,050 (Position Closed) |
Filing History |
| 2024-02-14 4:43 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Omega Fund VI, L.P. | 2,157,623 8.100% |
2,157,623 (New Position) |
Filing History |
| 2023-02-13 4:46 pm Unchanged |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Omega Fund VI, L.P. | 2,415,050 5.200% |
0 (Unchanged) |
Filing History |
| 2022-02-14 3:21 pm Purchase |
2021-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
Omega Fund VI, L.P. | 2,415,050 8.200% |
2,415,050 (New Position) |
Filing History |
| 2022-02-14 2:57 pm Purchase |
2021-12-31 | 13G | Ikena Oncology, Inc. IKNA |
Omega Fund VI, L.P. | 2,249,123 6.300% |
2,249,123 (New Position) |
Filing History |
| 2022-02-14 2:09 pm Purchase |
2021-12-31 | 13G | Imago BioSciences, Inc. IMGO |
Omega Fund VI, L.P. | 3,018,737 9.000% |
3,018,737 (New Position) |
Filing History |
| 2021-02-12 2:13 pm Purchase |
2020-08-11 | 13G | Checkmate Pharmaceuticals, Inc. CMPI |
Omega Fund VI, L.P. | 1,335,050 6.200% |
1,335,050 (New Position) |
Filing History |
| 2021-02-12 1:46 pm Purchase |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Omega Fund VI, L.P. | 2,161,023 9.300% |
2,161,023 (New Position) |
Filing History |